Corvia Medical
corviamedical.com
Actively hiring
Health Care
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$15.1M
2 rounds on record
Latest round
$8.9M
Venture round · Jun 2025 · 15 mo ago
Team
51-200
employees, estimated range
Backers
1
Lumira Ventures
The money's age
Due for its next round
15 months since the last round · not hiring
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Jun 12, 2025
Raised a round Venture round $8.9M · SEC Form D
Dec 20, 2024
Certified Corvia Medical Achieves CE Certification for Atrial Shunt Under New EU MDR Standards · corviamedical.com
Jan 15, 2021
Raised a round Venture round $6.3M · SEC Form D
Nov 17, 2020
Certified Corvia Medical Completes Randomization In REDUCE LAP-HF II Pivotal Trial And Gains FDA Authorization To Provide Continued Access For The Corvia Atria… · prnewswire.co.uk
2010
Founded
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Jun 2025 | $8.9M | — | SEC Form D |
| Venture round | Jan 2021 | $6.3M | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | Corvia Medical, Inc. | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
George FazioExecutive Officer, DirectorSEC Form D
Dan CurtisExecutive OfficerSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
Lumira Ventures Similar startupsby what they do, their industry and backers
Discover proactive heart failure management with the FDA-approved Cordella platform that guides care and improves outcomes based on…
Our mission is to improve the quality of life of patients with myocardial infarction (MI) and heart failure by providing novel…
-Our Mission 誰もが空の恩恵を享受できる世界を実現する トラジェクトリーは、管制の自動化を通じて、誰もが安全かつ簡単に無人航空機の恩恵を享受できる社会を実現し、人々のQOL（Quality of Life）の向上に貢献するというミッションを掲げています。.
There are over 60 million people with heart failure worldwide. It is the leading cause of hospitalization in people over 65.
Damona Pharmaceuticals is developing precision neuromedicines to reverse cognitive deficits associated with brain disorders.associated with…
Replacing Hearts. Restoring Lives. HEART FAILURE Heart failure is a global epidemic affecting at least 26 million people worldwide, 6.2…
News
Corvia Medical Announces Completion of RESPONDER-HF Trial Enrollment
Ongoing follow-up of 266 randomized patients to inform final outcomes TEWKSBURY, MA - May 14, 2026 - Corvia Medical, Inc., a company dedicated to transforming the treatment of heart failure, today announced the completion of enrollment in the RESPONDER-HF
Read more
Report
Five-Year REDUCE LAP-HF II Outcomes Demonstrate Durable Benefit of the Corvia Atrial Shunt in Heart Failure Patients
41% reduction in heart failure hospitalizations and significant ongoing quality-of-life improvements for responder phenotype TEWKSBURY, MA - March 3, 2026 - Corvia Medical, Inc, a company dedicated to transforming the treatment of heart failure, today ann
Read more
Report
Scripps La Jolla testing new heart device that offers hope for patients with heart failure
A tiny implantable heart device is changing lives for patients with HFpEF heart failure. Scripps La Jolla is among 65 hospitals worldwide testing this breakthrough technology.
Read more
Report
Media Professional Press Release Information for AHN
Allegheny Health Network's media relations team is dedicated to providing reporters and other members of the news media with the assistance they need.
Read more
Report
Corvia Medical: $55 Million Raised For Treating Heart Failure
Corvia Medical, a company dedicated to transforming the treatment of heart failure, announced the closing of a $55 million funding round from its existing investment syndicate, which includes Third Rock Ventures, General Catalyst Partners, AccelMed, Lumir
Read more
Report
Pro access
Upgrade to see all 37 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.
People
George Fazio
Executive Officer, Director
Dan Curtis
Executive Officer
Paul LaViolette
Director
Gerry Brunk
Director
Hemant Taneja
Director
Mark Levin
Director
David Celermajer
Director
Uri Geiger
Director
Kevin Gillis
Director
Gerald Brunk
Director
Irit Yaniv
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Tewksbury
United States
HQ
CORPORATE HEADQUARTERS
50-200 est. staff
One Highwood Drive, Suite 300, Tewksbury, MA 01876